# Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease

> **NCT00976118** · PHASE2 · COMPLETED · sponsor: **AB Science** · enrollment: 34 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** masitinib (AB1010)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00976118
- **Lead sponsor:** AB Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-07
- **Final completion:** 2009-02
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976118, "Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00976118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*